Tao Xia
Ningbo, 315040, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Spatial control of cytokine-based therapeutics in pancreatic tumors via DNase I-responsive DNA frameworks.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: May 11, 2026
Dynamic alterations of site-specific N-glycoform and plasma proteasome signatures stratify chemotherapy benefit in pancreatic ductal adenocarcinoma.
Journal: Molecular & cellular proteomics : MCP
Published: April 03, 2026
Enriched Localized Electron Confined Ultrafine Pt NPs Sites for Selective Catalytic Hydrogenation in Sulfur-Containing Feedstocks.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: December 11, 2025
Extracellular Vesicle-Derived Adenosine as a Diagnostic Metabolic Biomarker for Pancreatic Ductal Adenocarcinoma.
Journal: Cancer research and treatment
Published: May 12, 2025
Interaction of vernodalin with p38 mitogen-activated protein kinase (p38 MAPK) and subsequent effects in lung cancer cell model.
Journal: International journal of biological macromolecules
Published: January 02, 2025
Pathologic Response of Phase III Study: Perioperative Camrelizumab Plus Rivoceranib and Chemotherapy Versus Chemotherapy for Locally Advanced Gastric Cancer (DRAGON IV/CAP 05).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 09, 2024
Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma following prior gemcitabine-based therapy (PAN-HEROIC-1): a phase 3 trial.
Journal: Signal transduction and targeted therapy
Published: March 28, 2024
Neoadjuvant radioimmunotherapy in pancreatic cancer enhances effector T cell infiltration and shortens their distances to tumor cells.
Journal: Science advances
Published: February 07, 2024
Factors predicting recurrence after left‑sided pancreatectomy for pancreatic ductal adenocarcinoma.
Journal: World journal of surgical oncology
Published: April 19, 2023
Reoperation for heterochronic intraductal papillary mucinous neoplasm of the pancreas after bile duct neoplasm resection: A case report.
Journal: World journal of gastrointestinal surgery
Published: March 24, 2023
Clinical outcome comparison of laparoscopic radical antegrade modular pancreatosplenectomy vs. laparoscopic distal pancreatosplenectomy for left-sided pancreatic ductal adenocarcinoma surgical resection.
Journal: Frontiers in surgery
Published: June 29, 2022
Last Updated: 09/26/2026